Other adverse events that occurred in this study were infections, urological problems, hematological problems and diabetes mellitus, but were not associated with a change in NFATc1 amplification (S1 Fig) The influences of adverse events on NFATc1 amplification will probably become clearer in a larger and prospective (multi-center) study. The gene discussed is NFATC1; the disease is diabetes mellitus.